# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-023050
Filing Date
2020-05-08
Accepted
2020-05-07 18:00:08
Documents
65
Period of Report
2020-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | acad-10q_20200331.htm iXBRL | 10-Q | 1857167
2 | EX-10.1 | acad-ex101_304.htm | EX-10.1 | 171878
3 | EX-10.2 | acad-ex102_303.htm | EX-10.2 | 55562
4 | EX-31.1 | acad-ex311_7.htm | EX-31.1 | 9472
5 | EX-31.2 | acad-ex312_8.htm | EX-31.2 | 9213
6 | EX-32.1 | acad-ex321_9.htm | EX-32.1 | 6330
7 | EX-32.2 | acad-ex322_6.htm | EX-32.2 | 6385
8 | GRAPHIC | gcgqvlf1dmgj000002.jpg | GRAPHIC | 36409
9 | GRAPHIC | gcgqvlf1dmgj000001.jpg | GRAPHIC | 24526
10 | GRAPHIC | gcgqvlf1dmgj000003.jpg | GRAPHIC | 36884
11 | GRAPHIC | gcgqvlf1dmgj000004.jpg | GRAPHIC | 25066
| Complete submission text file | 0001564590-20-023050.txt |  | 7039348

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL TAXONOMY EXTENSION SCHEMA | acad-20200331.xsd | EX-101.SCH | 39139
13 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | acad-20200331_cal.xml | EX-101.CAL | 55636
14 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | acad-20200331_def.xml | EX-101.DEF | 91463
15 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | acad-20200331_lab.xml | EX-101.LAB | 305321
16 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | acad-20200331_pre.xml | EX-101.PRE | 222235
45 | EXTRACTED XBRL INSTANCE DOCUMENT | acad-10q_20200331_htm.xml | XML | 1360081

Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 20857972
SIC: 2834 Pharmaceutical Preparations